Longo provided Q2 guidance: "we expect, total revenue between $100 million and $102 million, with Subscription Services revenue between $85 million and $87 million; gross margin to be in the range of ...

Narrow-moat Vertex Pharmaceuticals delivered softer-than-expected first-quarter results, as higher costs and weaker Trikafta revenue outside of the US weighed on the quarter's performance. While ...

More than 6 in 10 survey respondents say they expect their healthcare organizations to see higher revenue from value-based care arrangements this year than in 2024, according to a joint report from ...

StarHub's third-quarter service revenue declined 4.1%. The EBITDA growth of 4.5% and net profit growth of 11% are harder to evaluate, given they depended more on the levels of Dare+ spending, which is ...

CEO Joseph J. Ciaffoni reported record SUBLOCADE net revenue, led by solid U.S. performance, stating "Our top line performance positions us well for the remainder of the year and enables us to raise ...

Chairman & CEO Derek Leathers opened by acknowledging, "While the second quarter was more favorable, the third quarter presented some challenges, namely in our One-Way business. However, there are ...